Medical University of Silesia in Katowice — Katowice

Public research footprint of Medical University of Silesia in Katowice, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Polycythemia Vera · Relapsed Multiple Myeloma · Atrioventricular Block, Second and Third Degree · Cardiac Implantable Electronic Device Infections

Recently updated registry entries

NCT03165734 — A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia… (Active Not Recruiting)
NCT07509060 — HCL in Adults With T1DM, Markedly Elevated HbA1c, and Psychological Vulnerability (Active Not Recruiting)
NCT07013552 — Oritavancin for CIED Infections With MDR Gram-positive Cocci (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medical University of Silesia in Katowice?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.